Europe

European Drugmakers Slam EU Reform Proposals

European NGOs have welcomed the EU’s plans for an overhaul of pharmaceutical legislation – the first in two decades – presented this week in Brussels. The drugs industry, however, has expressed sharp criticism.

WEF’s Global Competitiveness Index 2018

Trump Signs “Seriously Flawed” Russia Sanctions Bill

Tighter US Sanctions on Russia Could Hurt Europe

EU Approves First Childhood Neuroblastoma Drug

China’s Investors Advance

The Chemical Footprint in Pharma

Global Competitiveness Index

Associations Warn EC on China Anti-dumping

EU Member States to Vote on Canada Trade Pact

Clariant and Kilfrost Scratch Europe De-icing Deal

Trends in Health-Care Logistics

Chances and Hurdles for Biosimilars

Leaving the Patent Cliff Behind

Significant Value Creation

Oxea Extends Partnership with IMCD to Strengthen Distribution of Amines in Europe

Following two years of successful co-operation, the global chemical company Oxea has extended its distribution partnership with the Dutch chemical distributor IMCD for its Amines in Europe.

Omni-Chem136 Announces Harke Group as New European Member

With Oil Prices Down, Energy Companies Need to Adopt a 'Cost Culture'

Arkema Starts up Thiochemicals Platform in Malaysia

Global Competitiveness Index

Building a Future-Proof Business

China’s rising salaries improve Europe’s competitiveness

Chemical Distributors and their Fight for Growth

The Biosimilar Market

VinylPlus’ Quest For Sustainability

EU States Deadlocked on Genetically Modified Maize Approvals

EU to Ban Pesticides Blamed for Harming Bees

High Naphtha Import Volumes to Hit Asia for the 5th Month

New ECHA Committee Starts Working for Safe Biocidal Products

Lanxess Central Eastern Europe Sees Sales Increase by 40%

Health Firms Demand Bills Overhaul from Spain to Stem Debt

U.S. Shale May Force More European Refinery Closures

Drugmakers, Academics Pool R&D in $265 Million EU Project

U.S. Shale Gas Revolution Throws Down the Gauntlet to Europe

A Numbers Game